Birdwatch Note
2024-07-31 22:38:49 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
La boxeadora Imane Khelif, no presentó cromosomas XY en sus estudios, los resultados indicaron que tenía altos niveles de testosterona y por eso fue descalificada. Imane Khelif NO es una mujer transgénero, es una mujer biológica. https://animalpolitico.com/tendencias/actualidad/boxeadora-imane-khelif-niveles-testosterona-trans?s=09
Written by D5445A5F98259A8E49AB3CD6912D51EADD575879FE505C3D5BB2462923440A2A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1818759420358410596
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1818778371750306294
- noteId - 1818778371750306294
- participantId -
- noteAuthorParticipantId - D5445A5F98259A8E49AB3CD6912D51EADD575879FE505C3D5BB2462923440A2A Participant Details
- createdAtMillis - 1722465529749
- tweetId - 1818759420358410596
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- La boxeadora Imane Khelif, no presentó cromosomas XY en sus estudios, los resultados indicaron que tenía altos niveles de testosterona y por eso fue descalificada. Imane Khelif NO es una mujer transgénero, es una mujer biológica. https://animalpolitico.com/tendencias/actualidad/boxeadora-imane-khelif-niveles-testosterona-trans?s=09
Note Ratings
| rated at | rated by | |
| 2024-08-09 18:14:21 -0500 | Rating Details | |
| 2024-08-01 21:50:46 -0500 | Rating Details | |
| 2024-08-01 21:37:02 -0500 | Rating Details | |
| 2024-08-01 20:47:17 -0500 | Rating Details | |
| 2024-08-01 15:43:11 -0500 | Rating Details | |
| 2024-08-01 15:27:22 -0500 | Rating Details | |
| 2024-08-01 11:47:32 -0500 | Rating Details | |
| 2024-08-01 11:45:34 -0500 | Rating Details | |
| 2024-08-01 11:05:40 -0500 | Rating Details | |
| 2024-08-01 10:53:37 -0500 | Rating Details | |
| 2024-08-01 10:05:03 -0500 | Rating Details | |
| 2024-08-01 10:01:50 -0500 | Rating Details | |
| 2024-08-01 09:47:25 -0500 | Rating Details | |
| 2024-08-01 09:43:54 -0500 | Rating Details | |
| 2024-08-01 09:30:07 -0500 | Rating Details | |
| 2024-08-01 09:18:27 -0500 | Rating Details | |
| 2024-08-01 09:11:55 -0500 | Rating Details | |
| 2024-08-01 09:10:22 -0500 | Rating Details | |
| 2024-08-01 09:07:38 -0500 | Rating Details | |
| 2024-08-01 09:03:19 -0500 | Rating Details | |
| 2024-08-01 08:55:23 -0500 | Rating Details | |
| 2024-08-01 08:54:59 -0500 | Rating Details | |
| 2024-08-01 08:54:22 -0500 | Rating Details | |
| 2024-08-01 08:53:49 -0500 | Rating Details | |
| 2024-08-01 08:46:02 -0500 | Rating Details | |
| 2024-08-01 08:44:45 -0500 | Rating Details | |
| 2024-08-01 08:41:34 -0500 | Rating Details | |
| 2024-08-01 08:37:38 -0500 | Rating Details | |
| 2024-08-01 08:30:24 -0500 | Rating Details | |
| 2024-08-01 08:23:41 -0500 | Rating Details | |
| 2024-08-01 08:15:06 -0500 | Rating Details | |
| 2024-08-01 08:10:43 -0500 | Rating Details | |
| 2024-08-01 07:40:36 -0500 | Rating Details | |
| 2024-08-01 07:24:36 -0500 | Rating Details | |
| 2024-08-01 07:20:25 -0500 | Rating Details | |
| 2024-08-01 06:46:26 -0500 | Rating Details | |
| 2024-08-01 06:18:54 -0500 | Rating Details | |
| 2024-08-01 05:53:36 -0500 | Rating Details | |
| 2024-08-01 05:52:50 -0500 | Rating Details | |
| 2024-08-01 05:37:28 -0500 | Rating Details | |
| 2024-08-01 05:26:41 -0500 | Rating Details | |
| 2024-08-01 04:51:46 -0500 | Rating Details | |
| 2024-08-01 04:48:41 -0500 | Rating Details | |
| 2024-08-01 04:11:38 -0500 | Rating Details | |
| 2024-08-01 03:26:29 -0500 | Rating Details | |
| 2024-08-01 03:11:36 -0500 | Rating Details | |
| 2024-08-01 02:57:23 -0500 | Rating Details | |
| 2024-08-01 02:56:28 -0500 | Rating Details | |
| 2024-08-01 02:45:38 -0500 | Rating Details | |
| 2024-08-01 02:37:32 -0500 | Rating Details | |
| 2024-08-01 01:43:58 -0500 | Rating Details | |
| 2024-08-01 01:38:33 -0500 | Rating Details | |
| 2024-08-01 00:59:10 -0500 | Rating Details | |
| 2024-08-01 00:04:54 -0500 | Rating Details | |
| 2024-08-01 00:02:19 -0500 | Rating Details | |
| 2024-07-31 23:19:28 -0500 | Rating Details | |
| 2024-07-31 23:08:20 -0500 | Rating Details | |
| 2024-07-31 22:39:58 -0500 | Rating Details | |
| 2024-07-31 22:35:44 -0500 | Rating Details | |
| 2024-07-31 22:23:35 -0500 | Rating Details | |
| 2024-07-31 21:42:15 -0500 | Rating Details | |
| 2024-07-31 21:35:25 -0500 | Rating Details | |
| 2024-07-31 21:33:24 -0500 | Rating Details | |
| 2024-07-31 21:10:13 -0500 | Rating Details | |
| 2024-07-31 20:03:00 -0500 | Rating Details | |
| 2024-07-31 19:42:15 -0500 | Rating Details | |
| 2024-08-02 04:34:51 -0500 | Rating Details |